4//SEC Filing
Dugan Margaret 4
Accession 0001909734-25-000006
CIK 0001422142other
Filed
Dec 1, 7:00 PM ET
Accepted
Dec 2, 4:48 PM ET
Size
9.1 KB
Accession
0001909734-25-000006
Insider Transaction Report
Form 4
Dugan Margaret
Chief Medical Officer
Transactions
- Award
Stock option (right to buy)
2025-12-01+650,000→ 650,000 totalExercise: $2.26Exp: 2035-12-01→ Common Stock (650,000 underlying) - Award
Restricted Stock Units
2025-12-01+55,309→ 55,309 total→ Common Stock (55,309 underlying)
Footnotes (3)
- [F1]Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the total shares subject to the option shall vest each month thereafter on the same day as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month) such that all shares of common stock subject to the option shall be fully vested on the four year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean December 1, 2025.
- [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Whitehawk Therapeutics, Inc. Common Stock.
- [F3]Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean December 1, 2025.
Documents
Issuer
Whitehawk Therapeutics, Inc.
CIK 0001422142
Entity typeother
Related Parties
1- filerCIK 0001909734
Filing Metadata
- Form type
- 4
- Filed
- Dec 1, 7:00 PM ET
- Accepted
- Dec 2, 4:48 PM ET
- Size
- 9.1 KB